Immune Surveillance in Multiple Sclerosis Patients Treated with Natalizumab

32. Stuve O, Marra C, Jerome K, Cook L, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Hemmer B, Monson NL and Racke MK , Ann Neurol , 2006; (59):743-747

Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients

28. Monson NL, Brezinschek HP, Brezinschek RI, Mobley A, Vaughan GK, Frohman EM, Racke MK, Lipsky PE , J Neuroimmunol , 2005; (158):170-81

Molecular Modeling of Cardiac Glycoside Binding by the Monoclonal Human Sequence Antibody 1B3

Paula S, Monson NL, Ball WJ, Jr , Proteins , 2005; (60):382-391

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions

30. Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK. , Arch Neurol , 2005; (62(9)):1345-56

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

29. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK , Arch Neurol , 2005; (62):258-64

Cerebrospinal fluid B cells from Multiple Sclerosis patients are subject to normal germinal center selection

36. Harp C., Lee J., Lambracht-Washington D., Frohman E., Racke M.K., and Monson NL , J Neuroimmunol , 2007; (183):189

Antigen Specificity of Clonally Expanded and Receptor Edited Cerebrospinal Fluid B cells from Patients with Relapsing Remitting MS

35. Lambracht-Washington D., O?Connor K.C., Jowdry A., Ward E.S., Rula K., Frohman E., Racke M.K., and Monson NL , J. Neuroimmunol , 2007; (186):164-176

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

37. Stuve O, Marra CM, Cravens PD, Singh MP, Hu W, Lovett-Racke A, Monson NL, Phillips JT, Tervaert JW, Nash RA, Hartung HP, Kieseier BC, Racke MM, Frohman EM, Hemmer B. , Arch Neurol , 2007; (64):169-76

Potential Role of Humoral Immunity in the Pathogenesis of Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE)

Martin, Maria del Pilar and Monson NL , Frontiers in Bioscience , 2007; (12):735-2749

Altered CD4:CD8 T cell Ratios in Cerebrospinal fluid of Natalizumab treated Multiple Sclerosis Patients

33. Stuve O, Marra C, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Gran?Maison F, Hemmer B, Monson NL, Racke MK , Archives of Neurology , 2006; (63):1383-1387